
Currently out of the existing stock ratings of Elliot Wilbur, 14 are a HOLD (13.33%), 91 are a BUY (86.67%).
Analyst Elliot Wilbur, has had 57.78% of price targets met with an average potential upside of 40.55%, reached in 494 days on average. Previously, Elliot Wilbur worked at RAYMOND JAMES, NEEDHAM.
Elliot Wilbur has documented 191 price targets and ratings displayed on 26 stocks. The coverage was on Healthcare, Financial Services sectors.
Most recent stock forecast was given on SLGL, Sol Gel Technologies Ltd at 11-Aug-2023.
Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS) on 11/7/2019. The price target of $4 was fulfilled within 26 days with a profit of $1.35 (50.94%), with a performance score of 19.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Jun-2020
4 years 6 months 3 days ago
(19-May-2022)
2/5 (40%)
$25.55 (57.48%)
136
Buy Since 16-Nov-2020
6 years 6 days ago
(16-Nov-2020)
0/3 (0%)
$1128.5 (658.02%)
Buy Since 12-Sep-2017
$280
6 years 11 months 28 days ago
(25-Nov-2019)
0/3 (0%)
$142.8 (104.08%)
Sell Since 23-Jul-2019
$77
7 years 3 months 30 days ago
(23-Jul-2019)
2/6 (33.33%)
$-12.6 (-14.06%)
9
Stocks Elliot Wilbur covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.